Randomized, double-blind, placebo-controlled parallel-group comparative study to investigate the effect of Oligonol on the reduction of body weight and body fat for healthy subjects.
Phase 2
- Conditions
- Healyhy subjects whose BMI is 23-30
- Registration Number
- JPRN-UMIN000031293
- Lead Sponsor
- Fuji Women's University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Person ingesting the drugs, supplements and health food products relating lipid metabolism (2)Patients with chronic disease and medicated (3)Heavy smoker (>21 pieces/day) (4)Heavy drunker(>20 g/day of alcohol) (5)Person who has the allergy with food and drug, especially, lychee, tea, gelatin, pork) (6)Pregnancy, willing the be pregnant, or breast-feeding. (7)Person who cannot stop taking excess polyphenolic ingredient such as tea and green tea (8)Person who is judged as unfit for the subject by the principal investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body weight, Body fat mass, Body fat percentage, BMI
- Secondary Outcome Measures
Name Time Method BDHQ, nutrient intake